Evidence map›Paper›PMID 41830498›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2026

APOE-mediated sex differences in microvascular pathology and AD-associated proteinopathies in the medial temporal lobe.

Francesco Bax, Jan Oltmer, Corinne A Auger, Anna Bonkhoff, Gillian T Coughlan, Alexandra Melloni, Methasit Jaisa-Aad, Jean Augustinack, Alberto Serrano-Pozo, Matthew P Frosch and 5 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Francesco BaxJ. Philip Kistler Stroke Research Center, Department of Neurology, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA.ORCID 0000-0003-1725-1175
Jan OltmerBetterDoc GmbH, Cologne, Germany.
Corinne A AugerMassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Charlestown, Massachusetts, USA.
Anna BonkhoffJ. Philip Kistler Stroke Research Center, Department of Neurology, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA.
Gillian T CoughlanDepartment of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Alexandra MelloniMassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Charlestown, Massachusetts, USA.
Methasit Jaisa-AadMassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Charlestown, Massachusetts, USA.
Jean AugustinackMassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Charlestown, Massachusetts, USA.
Alberto Serrano-PozoMassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Charlestown, Massachusetts, USA.
Matthew P FroschC.S. Kubik Laboratory for Neuropathology, Neuropathology Service, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA.
Steven M GreenbergJ. Philip Kistler Stroke Research Center, Department of Neurology, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA.
Teresa Gomez-IslaMassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Charlestown, Massachusetts, USA.
Bradley T HymanMassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Charlestown, Massachusetts, USA.
Susanne J van VeluwJ. Philip Kistler Stroke Research Center, Department of Neurology, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA.
Valentina PerosaJ. Philip Kistler Stroke Research Center, Department of Neurology, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA.

Funding

Research Education ComponentP30AG062421 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Sudeshna Das · 2019 to 2026
$36.5M
Perivascular Inflammation and Vascular Remodeling: A Common Cause of Hemorrhage in Cerebral Small Vessel Diseases?R56NS131387 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI VAN VELUW, SUSANNE JANNEKE · 2023 to 2023
$777k
Unraveling the mechanisms of microhemorrhages in cerebral amyloid angiopathyR00AG059893 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI VAN VELUW, SUSANNE JANNEKE · 2020 to 2022
$745k
Understanding the mechanistic link between vascular dysfunction and Alzheimers disease-related protein accumulation in the medial temporal lobeK99AG080134 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI PEROSA, VALENTINA · 2023 to 2024
$247k
Alzheimer's Association 243291Alzheimer's Association ABA-25-1373553Leducq Foundation for Cardiovascular Research 23CVD03NIH HHS K99AG080134NIH HHS P30AG062421NIH HHS R00AG059893NIH HHS R56NS131387
6 · The paper itself

Abstract

introductionCerebral small vessel disease (CSVD) contributes to the development of Alzheimer's disease (AD) dementia and co-occurs with AD-associated proteinopathies. However, how sex modulates the interaction between CSVD and AD-associated proteinopathies in the medial temporal lobe (MTL) remains unclear.

methodsOne hundred fifty-two autopsy cases from the Massachusetts Alzheimer's Disease Research Center were included. Deep-learning and semiquantitative scores were applied to MTL histological sections to obtain quantitative measures of proteinopathies and CSVD (cerebral amyloid angiopathy [CAA] and arteriolosclerosis). The effect of sex on AD-associated proteinopathies and the interaction between sex, CSVD, and apolipoprotein E (APOE) genotype were analyzed using linear mixed-effect models.

resultsIn women, higher CAA burden was associated with lower amyloid beta (Aβ) plaques but higher tau tangles density. No interaction effect was found for arteriolosclerosis. Women <75 years of age carrying the APOE ε4 allele had higher Aβ plaque burden than ε4 non-carriers. DISCUSSION: Our results highlight the complex effect of sex on microvascular and AD-associated pathologies in the MTL.

Indexed as

Alzheimer DiseaseApolipoproteins EArteriolosclerosisCerebral Amyloid AngiopathyCerebral Small Vessel DiseasesSex CharacteristicsTemporal LobeAgedAged, 80 and overApolipoprotein E4FemaleGenotypeHumansMalePlaque, AmyloidApolipoprotein E4Apolipoproteins EAlzheimer's diseaseAPOEarteriolosclerosisAβ plaquescerebral amyloid angiopathydeep‐learningmedial temporal lobemicrovascular pathologymixed‐pathologiesneuropathologypTDP‐43sex differencestau tangles

Identifiers

PMID41830498
PMCPMC13093349

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.